Markers of vascular endothelium activation in gout

Terapevticheskii Arkhiv

Volumn 77, Issue 5, 2005, Pages 62-65

  Lapkina, N A ^a   Baranov, A A ^a   Barskova, V G ^a   Abaitova, N E ^a   Yakunina, I A ^a  

^a NONE

Author keywords

Atherosclerosis; Gout; Markers of endothelial activation

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CAROTID ARTERIOGRAPHY; CLINICAL ARTICLE; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; ELECTROIMMUNOASSAY; ESSENTIAL HYPERTENSION; GOUT; HUMAN; INFECTION COMPLICATION; LABORATORY TEST; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SAMPLE SIZE; URIC ACID BLOOD LEVEL; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANTIGENS; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; GOUT; HUMANS; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 20444467558     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Consilium Medicum 2002; 8: 400-402.
2. Chapman P. T., Yarwood H., Harrison A. A. et al. Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1. Arthr. and Rheum. 1997; 40: 955-965.
3. Haskard D. O., Landis R. C. Interactions between leukocytes and endothelial cells in gout: lessons from a self-limiting inflammatory response. Arthr. Res. 2002; 4: (suppl. 3): 91-97.
4. Carlos T. M., Harlan J. M. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-2101.
5. Vestweber D., Blanks J. E. Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev. 1999; 79: 1141-1151.
6. Caterina R., Basta G., Lazzerini G. et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2646-2654.
7. Rohde L. E., Lee R. T., Rivero J. et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 1765-1770.
8. Robinson H., Wallace S. L., Masi A. T. et al. Proposed criteria for gout. In: Program Abstracts. 39-th Annual Meeting of the Am. Rheum. Assoc. Section of the Arthritis Foundation, New Orleans, June 4-6, 1975. 34-40.
9. James J. P., Stevens T. R. J., Hall N. D. et al. Factor VIII related antigen in connective tissue disease patients and relatives. Br. J. Rheumatol. 1990; 29: 6-9.
10. Highton J., Hessian P. A solid-phase enzyme immunoassay for C-reactive protein: clinical value and the effect of rheumatoid factor. J. Immunol. Meth. 1984; 68: 185-192.
11. Pober J. S., Gimbrone M. A., Lapierre L. A. et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 1986; 137: 1893-1896.
12. Jang Y., Lincoff A., Plow E., Topol E. Cell adhesion molecules in coronary artery disease. J. Am. Coll. Cardiol. 1994; 24: 1591-1601.
13. Price D. T., Loscalzo J. Cellular adhesion molecules and atherogenesis. Am. J. Med. 1999; 107: 85-97.
14. Blann A. D. Von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease. J. Rheumatol. 1993; 20: 1469-1471.
15. Wagner D. D., Bonfanti R. Von Willebrand factor and the endothelium. Mayo Clin. Proc. 1991; 66: 621-627
16. Blann A. D., Dobrotova M., Kubisz P., McCollum C. N. Von Willebrand factor, soluble P selectine, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thrombos. Haemostas. 1995; 74: 626-631.
17. Jager A., van Hisbergh V. W. M., Kostense P. J. et al. Von Willebrand factor, C-reactive protein and 5-year mortality in diabetic and nondiabetic subjects. Arterioscler. Thromb. Vasc. Biol. 1999; 19: 3071-3078.
18. Jansson J. H., Nilsson T. K., Johnson O. Von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction. Br. Heart J. 1991; 66: 351-357.
19. Blann A. D., Wainwright A. C., Sheeran T. P., Emery P. Venostasis, subclinical vasculitis and von Willebrand factor antigen. Br. J. Rheumatol. 1991; 30: 373-375.
20. Woolf A. D., Wakerley G., Wallington T. B. et al. Factor VIII related antigen in the assessment of vasculitis. Ann. Rheum. Dis. 1987; 46: 441-447.
21. Norborg E., Andersen R., Tengborn L. et al. Von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis. Ann. Rheum. Dis. 1991; 50: 316-320.
22. Pottinger B. E., Read R. C., Paleolog E. M. et al. Von Willebrand factor is an acute phase reactant in man. Thrombos. Res. 1989; 53: 387-394.